產品展示
【PTH (1－34)】人甲狀旁腺素（1－34）
點擊次數：17發布時間：2016/9/18 19:42:21
更新日期：2018/3/30 11:58:47
所 在 地：中國大陸
產品型號：
優質供應
詳細內容
〖【PTH (1－34)】人甲狀旁腺素（1－34）〗齊一生物銷售：021－6034 8496；181214 53965；173021 04490
齊一生物專業代理ProSpec進口蛋白、Sigma西格瑪.美國BD.賽默飛thermofisher.日本wako.TCL.默克Merck .美國AMRESCO.Invitrogen.日本榮研化學株式會社.EP（歐洲藥典）.USP（美國藥典）.BP（英國藥典）加拿大TRC等試劑.標準品.對照品原裝產品,正品原裝質量,貨期短價格優惠！〖【PTH (1－34)】人甲狀旁腺素（1－34）〗歡迎前來選購齊一生物科技（上海）有限公司客服熱線：４００�。梗梗保啊。保梗罚埃玻保叮埃常础。福矗梗毒W站：http://www.qiyibio.com
4506203 artus HBV RG PCR Kit (24) RUO CNY
4509005 artus WNV LC RT－PCR Kit (96) RUO CNY
80311 AllPrep DNA/RNA 96 Kit (4) CNY
76554 RNAprotect Animal Blood Tubes 500µl (50) CNY
76163 RNAlater TissueProtect Tubes (20x5ml) For stabilization of RNA in 20 x 500 mg tissue samples: 20 screw－top tubes containing 5 ml RNAlater RNA Stabilization Reagent each CNY
74182 RNeasy 96 Kit (12) For 12 x 96 total RNA preps: 12 RNeasy 96 Plates, Elution Microtubes CL (1.2 ml), Caps, RNase－free Reagents ａnd Buffers CNY
74136 RNeasy Plus Mini Kit (250) CNY
28004 MinElute PCR Purification Kit (50) 50 MinElute Spin Columns, Buffers, Collection Tubes (2 ml) CNY
74124 RNeasy Protect Mini Kit (50) RNAlater RNA Stabilization Reagent (50 ml), 50 RNeasy Mini Spin Columns, Collection Tubes (1.5 ml ａnd 2 ml), RNase－free Reagents ａnd Buffers CNY
19588 Elution Microtubes CL (24 x 96) CNY
19133 QIAGEN Proteinase K (10) 10 ml (>600 mAU/ml, solution) CNY
19076 Buffer ATL 200 ml Tissue Lysis Buffer for 1000 preps CNY
19048 EndoFree Plasmid Buffer Set Buffers P1, P2, P3, QBT, QC, QN, ER, TE, Endotoxin－free water, RNase A; for 10 plasmid mega－ or 5 gigapreps (endotoxin－free) CNY
12961 QIAGEN Plasmid Plus Maxi Sample Kit (5) QIAGEN Plasmid Plus Kits enable ultrafast, large－scale plasmid purification of pure plasmid DNA. The use of a vacuum manifold allows purification of up to 12 (Mega ａnd Giga) or up to 24 (Midi ａnd Maxi) samples in parallel with low hands－on needs. Low elution volumes yield highly concentrated plasmid DNA for direct use without ethanol precipitation. QIAGEN Plasmid Plus Kits also feature a novel wash buffer for endotoxin reduction. CNY 〖【PTH (1－34)】人甲狀旁腺素（1－34）〗
12243 QIAfilter Plasmid Midi Kit (25) 25 QIAGEN－tip 100, Reagents, Buffers, 25 QIAfilter Midi Cartridges CNY
12123 QIAGEN Plasmid Mini Kit (25) 25 QIAGEN－tip 20, Reagents, Buffers CNY
133276 NeXtalStock Spermine (100) CNY
4503065 artus CMV LC PCR Kit (96) CE CNY
6000－5000 Specimen Collection Tubes CNY
5000－1430 MST Vortexer II － FoamFeetAssembly, 110V CNY
5128－1220 Specimen Transport Medium (STM) CE CNY
5123－1220 Female Swab Specimen Collection KitTM CNY
5100－1400IVD hc2 Sample Conversion Kit CNY
EA11424 EASYartus BKV RG_II CNY
5050－1075 V.1 CD Rom Manual, MST Vortexer 2 CNY
EA10124 EASYartus EBV RG PCR Kit 2 CNY
BR－02 DxS B－RAF Mutation Test Kit CNY
9240729 Tubing, 3/8"OD , Red, AP CNY
9240719 Cable Carrier, Capper, Elevator, AP CNY
9240701 O－Ring, Shaker, Lower Body, AP96/196 CNY
9240696 Fitting, Barbed, 1/4" ID tube, AP CNY
9243651 Comprehen Valid., QIAgility """The Comprehensive Validation Support plan specific to a laboratory＇s needs will incorporate all of the requirements for the internal validation guidelines from the FBI＇s Quality Assurance Standards (QAS).
The Comprehensive Validation Support service includes all travel ａnd labor charges for up to 20 days by the QIAGEN Validation Team. Typically, one week will be required to extract, quantify, ａnd amplify the validation study samples ａnd may require multiple individuals. Usually, two weeks is required to analyze the data ａnd one week to write the final report. The expected time period to complete the Comprehensive Validation is six weeks. The actual time may vary depending on resource availability, including laboratory time dedicated to validation activities.
Lab Work – The QIAGEN specialist(s) will travel to the laboratory to conduct the on－site validation lab work. The QIAGEN specialist team will perform ａnd complete all extractions, quantifications, amplfications, ａnd capillary electrophoresis. The laboratory is responsible for providing systems/protocols that may be needed (generally laboratory SOPs, ex. interpretation guidelines). Additionally, the laboratory staff may be required to provide additional data needed for interpretation (ex. quantification/amplification/CE results) during the data review phase of the validation.
Once the final scope of the validation is determined, QIAGEN will provide a quote for all consumables required for the validation. Non－QIAGEN chemistry ａnd accessories are not included ａnd should be purchased to cover the validation experimental design including qPCR, STR, NIST standards, required samples types (blood, semen, buccal samples) ａnd required substrates (swabs, materials, etc). For planning purposes ａnd to ensure a smooth process, the Customer is expected to have all materials on－hand ａnd inventoried one (1) week prior to the validation start date.
Data Analysis – The Comprehensive Validation Support plan encompasses data collection (quants, amps, CE) during the on－site visit. The laboratory may be responsible for sharing (typically electronically via e－mail) any validation data requested after the on－site visit. A QIAGEN specialist will complete all of the data analysis produced from the validation study design. This includes qPCR (quant) ａnd STR (amp) analysis ａnd linkage to starting samples.
Validation data CD/flashdrive – QIAGEN will review the validation data ａnd draft a validation summary document, ensuring compliance with the FBI＇s QAS requirements/standards. QIAGEN will send validation data in an electronic format (email/CD/flashdrive) to the laboratory. The laboratory is responsible for final compilation, any format change preferences, review ａnd signoff of the validation report. The documentation provided by QIAGEN will aide in demonstrating compliance with all accreditation guidelines during laboratory audits. Should a hard copy of the validation study be preferred, the laboratory is required to specify prior to the onset of the validation.
Post－validation QIAGEN－to－Laboratory Transfer – Following completion of the validation ａnd generation of the draft validation summary document, a designated member of the QIAGEN validation team will review the validation with the Lab Manager ａnd the Technical Leader. Following sign off on the validation report, training of the laboratory DNA staff will occur. Refer to the Post－validation Competency Training for additional information. """ CNY
218076 miScript SYBR Green PCR Kit (2000) CNY
271906 cattletype Milk Prep Kit (50) CNY
289980 intype IC－DNA (1ml) CNY
280437 virotype BTV RT－PCR Kit (480) CNY
932836 #QIAsymphony Ni－NTA Denat. Kit (384) CNY
800511 Verification Sequencing / DNA production CNY
9238243 ZLV BioRobot M96 User Manual CNY 〖【PTH (1－34)】人甲狀旁腺素（1－34）〗
9019988 ZLV Mainboard, QGY CNY
9020553 Foam angle, transport box, QIAC CNY
9020582 X－Motor, DML3000 CNY
9020584 Y－Belt, DML3000 320 Teeth CNY
9020594 Enclosure, DML3000 CNY
9021006 Motor, Pipettor Y, DCU CNY
9236333 Sample Loop CNY
9013382 Shaker adapter, microplate, LHS CNY
9013275 Motor, gripper, handler T/L, BR3000 CNY
9013269 Fitting, PA tubing M6x1, 2.25mm, (10) CNY
9013210 Cabling kit, moving, BR8000 CNY
9013198 Tubing,pres.sen.con.auto vac,BR8000v1.00 CNY
9013188 Valve set, pressure relaese, dispenser, CNY
9011730 Cable, level sensor, BR8000 CNY
└ 膀胱上皮細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 膀胱平滑肌細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 腎動脈內皮細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 腎動脈平滑肌細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 腎小管上皮細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 腎小球內皮細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 腦動脈血管內皮細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 腦動脈血管平滑肌細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 腦靜脈血管內皮細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 腦靜脈血管平滑肌細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 腦膜細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 神經元細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 神經膠質細胞總RNA 1μg/1μl（10μg/20ug/50ug） 〖【PTH (1－34)】人甲狀旁腺素（1－34）〗
└ 海馬神經元細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 腦微血管內皮細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 腦成纖維細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 神經小膠質細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 雪旺氏細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 骨細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 滑膜細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 骨骼肌細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 表皮角化細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 真皮成纖維細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 軟骨細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 破骨細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 皮膚肥大細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 前脂肪細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 胰島β細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 胰腺星狀細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 胰腺導管上皮細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 頜下腺上皮細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 子宮內膜上皮細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 卵巢顆粒細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 視網膜微血管內皮細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 小梁網細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 視網膜色素上皮細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 視網膜muller細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 虹膜色素上皮細胞總NRA 1μg/1μl（10μg/20ug/50ug）
└ 晶狀體上皮細胞總RNA 1μg/1μl（10μg/20ug/50ug） 〖【PTH (1－34)】人甲狀旁腺素（1－34）〗
└ 角膜上皮細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 角膜內皮細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 視網膜神經節細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 淋巴內皮細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 淋巴成纖維細胞總RNA 1μg/1μl（10μg/20ug/50ug）
└ 外周血白細胞總RNA 1μg/1μl（10μg/20ug/50ug）
原代細胞總DNA 1μg/1μl（10μg/20ug/50ug）
正常人組織源性原代細胞總DNA 1μg/1μl（10μg/20ug/50ug）
└ 肺微血管內皮細胞總DNA 1μg/1μl（10μg/20ug/50ug）
└ 肺大動脈內皮細胞總DNA 1μg/1μl（10μg/20ug/50ug）
└ 肺大動脈平滑肌細胞總DNA 1μg/1μl（10μg/20ug/50ug）
└ 肺大靜脈內皮細胞總DNA 1μg/1μl（10μg/20ug/50ug）
└ 肺大靜脈平滑肌細胞總DNA 1μg/1μl（10μg/20ug/50ug）
└ 肺動脈成纖維細胞總DNA 1μg/1μl（10μg/20ug/50ug）
└ 肺泡上皮細胞總DNA 1μg/1μl（10μg/20ug/50ug）
└ 氣管上皮細胞總DNA 1μg/1μl（10μg/20ug/50ug）
